Intracerebroventricular administration of chondroitinase ABC reduces acute edema after traumatic brain injury in mice

Finan, John D.; Cho, Frances S.; Kernie, Steven G.; Morrison III, Barclay

Brain edema is a significant challenge facing clinicians managing severe traumatic brain injury (TBI) in the acute period. If edema reaches a critical point, it leads to runaway intracranial hypertension that, in turn, leads to severe morbidity or death if left untreated. Clinical data on the efficacy of standard interventions is mixed. The goal of this study was to validate a novel therapeutic strategy for reducing post-traumatic brain edema in a mouse model. Prior in vitro work reported that the brain swells due to coupled electrostatic and osmotic forces generated by large, negatively charged, immobile molecules in the matrix that comprises brain tissue. Chondroitinase ABC (ChABC) digests chondroitin sulfate proteoglycan, a molecule that contributes to this negative charge. Therefore, we administered ChABC by intracerebroventricular (ICV) injection after controlled cortical impact TBI in the mouse and measured associated changes in edema.

Almost half of the edema induced by injury was eliminated by ChABC treatment.

ICV administration of ChABC may be a novel and effective method of treating post-traumatic brain edema in the acute period.


  • thumnail for 13104_2016_Article_1968.pdf 13104_2016_Article_1968.pdf application/pdf 898 KB Download File

Also Published In

BMC Research Notes

More About This Work

Academic Units
Biomedical Engineering
Published Here
January 30, 2017